Jiang Zixuan, Harrison David E, Parsons Makayla E, McClatchy Susan, Jacobs Lawrence, Pazdro Robert
Department of Foods and Nutrition, University of Georgia, 305 Sanford Drive, Athens, GA, 30602, USA.
The Jackson Laboratory, Bar Harbor, ME, 04609, USA.
Mamm Genome. 2016 Oct;27(9-10):460-8. doi: 10.1007/s00335-016-9655-6. Epub 2016 Jul 8.
Adipose-derived stromal cells (ADSCs) exhibit significant potential as therapeutic agents to promote tissue regeneration. Success of ADSC-based therapies is dependent upon efficient cell expansion in vitro as well as postinjection survival in the caustic milieu of damaged tissue. Genetic background regulates ADSC proliferative capacity and stress resistance, but the extent of the genetic effect size is not completely defined. The present study aimed to quantify phenotypic ranges and heritability of in vitro ADSC characteristics. ADSCs were isolated from mice representing 16 genetically diverse inbred mouse strains, including 12 classical inbred strains and four wild-derived strains. Cells were grown in vitro, and proliferative capacity and oxidative stress resistance were assessed. The fold change for ADSC growth ranged from 0.87 (BALB/cByJ) to 23.60 (POHN/DehJ), relative to original seeding density. The heritability of proliferative capacity was estimated to be 0.6462 (p = 9.967 × 10(-15)), and this phenotype was not associated with other ADSC traits. Cell viability following H2O2 treatment ranged from 39.81 % (CAST/EiJ) to 91.60 % (DBA/2 J), and the heritability of this phenotype was calculated as 0.6146 (p = 1.22 × 10(-12)). Relationships between cell viability and weight of the donor fat pad were also discovered. Donor genetic background is a major determinant of in vitro ADSC phenotypes. This study supports the development of forward genetics strategies to identify genes that underlie ADSC phenotypic diversity, which will inform efforts to improve cell-based therapies.
脂肪来源的基质细胞(ADSCs)作为促进组织再生的治疗剂具有巨大潜力。基于ADSC的疗法的成功取决于体外有效的细胞扩增以及在受损组织的苛刻环境中的注射后存活。遗传背景调节ADSC的增殖能力和抗应激能力,但遗传效应大小的程度尚未完全确定。本研究旨在量化体外ADSC特征的表型范围和遗传力。从代表16种遗传多样的近交小鼠品系的小鼠中分离出ADSCs,包括12种经典近交品系和4种野生来源品系。细胞在体外培养,并评估其增殖能力和抗氧化应激能力。相对于原始接种密度,ADSC生长的倍数变化范围为0.87(BALB/cByJ)至23.60(POHN/DehJ)。增殖能力的遗传力估计为0.6462(p = 9.967×10(-15)),并且该表型与其他ADSC特征无关。H2O2处理后的细胞活力范围为39.81%(CAST/EiJ)至91.60%(DBA/2 J),该表型的遗传力计算为0.6146(p = 1.22×10(-12))。还发现了细胞活力与供体脂肪垫重量之间的关系。供体遗传背景是体外ADSC表型的主要决定因素。本研究支持开发正向遗传学策略以鉴定构成ADSC表型多样性基础的基因,这将为改善基于细胞的疗法的努力提供信息。